Literature DB >> 22546772

Obesity and the risk and outcome of infection.

R Huttunen1, J Syrjänen.   

Abstract

The interactions between obesity and infectious diseases have recently received increasing recognition as emerging data have indicated an association between obesity and poor outcome in pandemic H1N1 influenza infection. Obesity is an established risk factor for surgical-site infections, nosocomial infections, periodontitis and skin infections. Several studies indicate that acute pancreatitis is more severe in the obese. Data are controversial and limited as regards the association between obesity and the risk and outcome of community-acquired infections such as pneumonia, bacteremia and sepsis and obesity and the course of HIV infection. As the cause-effect relationship between obesity and infection remains obscure in many infectious diseases, further studies are warranted. The consequences of obesity may have substantial effects on the global burden of infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22546772     DOI: 10.1038/ijo.2012.62

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  179 in total

Review 1.  Obesity-driven disruption of haematopoiesis and the bone marrow niche.

Authors:  Benjamin J Adler; Kenneth Kaushansky; Clinton T Rubin
Journal:  Nat Rev Endocrinol       Date:  2014-10-14       Impact factor: 43.330

2.  Impact of Obesity on Ventricular Assist Device Outcomes.

Authors:  Abhishek Jaiswal; Lauren K Truby; Astha Chichra; Rashmi Jain; Leann Myers; Nirav Patel; Veli K Topkara
Journal:  J Card Fail       Date:  2019-10-13       Impact factor: 5.712

3.  Exacerbated Staphylococcus aureus Foot Infections in Obese/Diabetic Mice Are Associated with Impaired Germinal Center Reactions, Ig Class Switching, and Humoral Immunity.

Authors:  Christopher W Farnsworth; Eric M Schott; Abigail Benvie; Stephen L Kates; Edward M Schwarz; Steven R Gill; Michael J Zuscik; Robert A Mooney
Journal:  J Immunol       Date:  2018-06-01       Impact factor: 5.422

4.  Phosphorylation of glycogen synthase kinase-3β in metabolically abnormal obesity affects immune stimulation-induced cytokine production.

Authors:  C-L Yen; W-C Chao; C-H Wu; Y-F Huang; C-S Chang; Y-S Tsai; C-F Lin; C-C Shieh
Journal:  Int J Obes (Lond)       Date:  2014-05-23       Impact factor: 5.095

5.  Guillain-Barré syndrome following elective spine surgery.

Authors:  Nikhil Sahai; Ki Soo Hwang; Arash Emami
Journal:  Eur Spine J       Date:  2016-05-09       Impact factor: 3.134

6.  Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m(2)) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoring.

Authors:  Manjunath P Pai; Piergiorgio Cojutti; Federico Pea
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

7.  Understanding the comparative molecular field analysis (CoMFA) in terms of molecular quantum similarity and DFT-based reactivity descriptors.

Authors:  Alejandro Morales-Bayuelo; Ricardo A Matute; Julio Caballero
Journal:  J Mol Model       Date:  2015-05-28       Impact factor: 1.810

8.  Association between preoperative 25-hydroxyvitamin D level and hospital-acquired infections following Roux-en-Y gastric bypass surgery.

Authors:  Sadeq A Quraishi; Edward A Bittner; Livnat Blum; Mathew M Hutter; Carlos A Camargo
Journal:  JAMA Surg       Date:  2014-02       Impact factor: 14.766

Review 9.  Multi-etiological Perspective on Child Obesity Prevention.

Authors:  Tom Baranowski; Kathleen J Motil; Jennette P Moreno
Journal:  Curr Nutr Rep       Date:  2019-01-16

Review 10.  Tissue Immunometabolism: Development, Physiology, and Pathobiology.

Authors:  Kevin Man; Vassily I Kutyavin; Ajay Chawla
Journal:  Cell Metab       Date:  2016-09-29       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.